Global Point-Of-Care Testing Market Manufacturing Process, Raw Materials, Cost and Revenue 2017 to 2024

The Market of Global Point-Of-Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

  • The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
  • The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Your Free Sample Report @

Market Segmentation: 

Fragment-based Drug Discovery Market Value Projected to Expand by 2023

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Combinational chemistry and high-throughput screening are some of the more recently introduced practices that have helped make fragment-based drug discovery programs a lot faster and cheaper than before.

Additionally, as the usage of fragment-based drug discovery grows in the field of discovering weaker inhibitors, biophysical techniques become extremely useful. These techniques can be used to measure binding within fragment compounds that possess low affinity for binding.

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market Estimated to Flourish by 2020

Several studies have shown that a large number of deaths are caused due to cross contamination and infection in hospital settings in India. To keep such unfortunate events at bay, it is important to use sterilizers and chemical disinfectors. Sterilizers and chemical disinfectors are antimicrobial agents especially used for surgical and dental equipment as well as in living tissues to kill or destroy microorganisms that could cross-contaminate and infect patients at the surgical site.

Mouth Ulcers Treatment Market Projected to Gain Significant Value by 2020

Mouth ulcers are non-critical and are formed due to oral injuries or wounds affecting the mucous membrane. Some of the factors resulting in the formation of mouth ulcers are stress, infection, injury, allergy, nutritional deficiencies, or genetic tendency, which further leads to intense pain. The inclination of consumers towards a healthy lifestyle is estimated to offer promising opportunities for the key players operating in the global mouth ulcer treatment market across the globe. The increasing level of competition and the emergence of innovative products are likely to encourage the growth of the global mouth ulcers market throughout the forecast period.

Circulating Tumor Cells Prognostic Technologies Market to Reap Excessive Revenues by 2020

The global circulating tumor cells prognostic technologies market are rising in demand due to increasing demand for diagnostic technologies. This rise in demand for these technologies are primarily due to prevalence rate of cancer. Huge application scope of these technologies are dependent on safety of patients. Substantial Rise in therapeutic monitoring is rising the demand for the market. Increased death rates due to development of metastases and hematogenous dissemination of cancer is also boosting the need for detection of circulating tumor cells. Novel technologies for detection of circulating tumor cells are rising in demand due to many clinical trials including them as their secondary end points and in their translation research programs. The global market is expecting wider implementation possibilities of circulating tumor cells prognostic technologies in the coming years due to increasing rate of research and development activities conducted for developing personalized medicines.

Liquid Biopsy Market Value Projected to Expand by 2026

Liquid biopsy is a minimally invasive test to assess cancer genetic status based on the analysis of circulating biomarkers that are present in the plasma component of the blood. Liquid biopsies are majorly utilized in the field of oncology. Liquid biopsy can improve and/or resolve several inherent problems found with current cancer treatment, enabling early cancer detection, mutation detection, tumor monitoring during treatment, and recurrence monitoring via a non-invasive blood draw. In addition to being non-invasive, liquid biopsies have the potential to detect cancer before substantial tumor formation, assess multiple mutations within the tumor (reducing heterogeneity concerns), quantitatively monitor treatment progress, and identify new mutations as they emerge as well as monitor for recurrence to detect cancer before imaging-detectable tumor formation or metastasis. In addition to oncology, liquid biopsies are applicable in prenatal testing and transplant care.

Immunoassay Market to Develop Rapidly by 2026

The global Immunoassay Market is expanding at a rapid pace due to high prevalence and rise in incidence of chronic, acute, and infectious diseases across the globe. The market was valued at US$ 16.54 Bn in 2017 and is projected to expand at a CAGR of 6.2% from 2018 to 2026 to reach US$ 28.61 Bn by 2026. The global immunoassay market is driven by technological advancements in the development of new immunoassays and analyzers and demographic and life changes favoring rapid, preventive, and predictive diagnosis.

Biopharmaceutical Fermentation Systems Market to Record an Exponential CAGR by 2026

The global Biopharmaceutical Fermentation Systems Market was valued at around US$ 10.0 Bn in 2017 and is anticipated to expand at a CAGR of more than 6.0% from 2018 to 2026 to reach a value of around US$ 17.8 Bn in 2026. Emphasis on the development and marketing of innovative products and solutions such as single-use systems and continuous bioprocessing is likely to drive the biopharmaceutical fermentation systems market market. Moreover, expansion by key players in emerging markets through contracts and collaborations is anticipated to propel the market in the coming years. For instance, expansion in Asia Pacific through flexible and modular manufacturing facility solutions and collaboration with biopharmaceutical manufacturers to develop and improve bioprocess products.

Hematology Diagnostics Market to be at Forefront by 2026

Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets. The analysis for hematologic disorders is related to disease monitoring, prognosis, diagnosis, and screening. Rise in prevalence of blood disorders, technological advancements and introduction of new technically advanced fully automated hematology analyzers, significant demand for laboratory automation, and increase in consolidation among market players and diagnostic laboratories are key factors that are expected to drive the global Hematology Diagnostics Market during the forecast period.

Surgical Drainage Devices Market to Surge at a Robust Pace by 2026

Surgical drainage devices are equipment that drain excess fluid or air from the operation site or wound so that the risk of formation of hematoma is reduced and wound healing process is accelerated. The global Surgical Drainage Devices Market was valued at US$ 2.9 Bn in 2017 and is anticipated to expand at a CAGR of 4% from 2018 to 2026 to reach US$ 4 Bn by 2026.